Eco-genotoxicity of six anticancer drugs using comet assay in daphnids

Journal of Hazardous Materials

Volumn 286, Issue , 2015, Pages 573-580

  Parrella, Alfredo ^a   Lavorgna, Margherita ^a   Criscuolo, Emma ^a   Russo, Chiara ^a   Isidori, Marina ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Anticancer drugs; Ceriodaphnia dubia; Daphnia magna; Genotoxicity; Mutagenicity

Indexed keywords

ESCHERICHIA COLI; PLATINUM COMPOUNDS; REPAIR; SALMONELLA; SYSTEMS ENGINEERING;

ANTICANCER DRUG; CERIODAPHNIA DUBIA; DAPHNIA MAGNA; GENOTOXICITIES; MUTAGENICITY;

ASSAYS;

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IMATINIB; MUTAGENIC AGENT;

ANATOMY; BACTERIUM; BIOASSAY; CANCER; CRUSTACEAN; DNA; DRUG; ECOTOXICOLOGY; MUTAGENICITY;

ARTICLE; COMET ASSAY; DAPHNIA MAGNA; DNA DAMAGE; ESCHERICHIA COLI; GENOTOXICITY; IN VITRO STUDY; MUTAGENICITY; NONHUMAN; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SOS CHROMOTEST; ANIMAL; CLADOCERA; DRUG EFFECTS; GENETICS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;

BACTERIA (MICROORGANISMS); CERIODAPHNIA DUBIA; CRUSTACEA; DAPHNIA MAGNA; DAPHNIIDAE; ESCHERICHIA COLI; SALMONELLA;

ANIMALS; ANTINEOPLASTIC AGENTS; CLADOCERA; COMET ASSAY; DNA DAMAGE; ESCHERICHIA COLI; MUTAGENS; SALMONELLA TYPHIMURIUM;

EID: 84921848933     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2015.01.012     Document Type: Article

References (34)

1. Kosjek T., Heath E. Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. Trends Analyt. Chem. 2011, 30(7):1065-1087.
2. Negreira N., de Alda M.L., Barceló D. On-line solid phase extraction-liquid chromatography-tandem mass spectrometry for the determination of 17 cytostatics and metabolites in waste, surface and ground water samples. J. chromatogr. A 2013, 1280:64-74.
3. Negreira N., de Alda M.L., Barceló D. Study of the stability of 26 cytostatic drugs and metabolites in wastewater under different conditions. Sci. Total Environ. 2014, 482-483:389-398.
4. Zounkova R., Odráška P., Doležalová L., Hilscherová K., Maršálek B., Bláha L. Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals. Environ. Toxicol. Chem. 2007, 26(10):2208-2214.
5. Brezovšek P., Eleršek T., Filipič M. Toxicities of four anti-neoplastic drugs and their binary mixtures tested on the green alga Pseudokirchneriella subcapitata and the cyanobacterium Synechococcus leopoliensis. Water Res. 2014, 52:168-177.
6. Parrella A., Lavorgna M., Criscuolo E., Russo C., Fiumano V., Isidori M. Acute and chronic toxicity of six anticancer drugs on rotifers and crustaceans. Chemosphere 2014, 115:59-66.
7. Besse J.P., Latour J.F., Garric J. Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic cytostatic and endocrine therapy drugs?. Environ. Int. 2012, 39:73-86.
8. Jha A.N. Ecotoxicological applications and significance of the comet assay. Mutagenesis 2008, 23(3):207-221.
9. Toolaram A.P., Kümmerer K., Schneider M. Environmental risk assessment of anti-cancer drugs and their transformation products: a focus on their genotoxicity characterization-state of knowledge and short comings. Mutat. Res. 2014, 760:18-35.
10. Park S.Y., Choi J. Cytotoxicity, genotoxicity and ecotoxicity assay using human cell and environmental species for the screening of the risk from pollutant exposure. Environ. Int. 2007, 33:818-822.
11. Park S.Y., Choi J. Genotoxic effects of nonylphenol and bisphenol a exposure in aquatic biomonitoring species: freshwater crustacean, Daphnia magna, and Aquatic midge, Chironomus riparius. Bull. Environ. Contam. Toxicol. 2009, 83(4):463-468.
12. David R.M., Dakic V., Williams T.D., Winter M.J., Chipman J.K. Transcriptional responses in neonate and adult Daphnia magna in relation to relative susceptibility to genotoxicants. Aquat. Toxicol. 2011, 104:192-204.
13. ISO, 10706 Water quality-determination of long term toxicity of substances to Daphnia magna Straus (Cladocera, Crustacean) 2000, International Organization for Standardization, Geneva, Switzerland.
14. ISO, 20665 Water quality-determination of chronic toxicity to Ceriodaphnia dubia in 7 days-population growth inhibition test 2008, International Organization for Standardization, Geneva, Switzerland.
15. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
16. Quillardet P., Hofnung M. The SOS chromotest: a review. Mutat. Res. 1993, 297:235-279.
17. EPA-600/4-82-068. Interim procedures for conducting the Salmonella/microsomal mutagenicity assay (Ames test), Las Vegas, USA, 1983.
18. Gačić Z., Kolarević S., Sunjog K., Kračun-Kolarević M., Paunović M., Knežević-Vukčević J., Vuković- Gačić B. The impact of in vivo and in vitro exposure to base analogue 5-FU on the level of DNA damage in haemocytes of freshwater mussels Unio pictorum and Unio tumidus. Environ. Pollut. 2014, 191:145-150.
19. Grisolia C.S., Cordeiro C.M.T. Variability in micronucleus induction with different mutagens applied to several species of fish. Genet. Mol. Biol. 2000, 23:235-239.
20. Pichler C., Filipič M., Kundi M., Rainer B., Knasmueller S., Mišík M. Assessment of genotoxicity and acute toxic effect of the imatinib mesylate in plant bioassays. Chemosphere 2014, 115:54-58.
21. Davidson D., Grenier J., Martinez-Marignac V., Amrein L., Shawi M., Tokars M., Aloyz R., Panasci L. Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells. Invest. New Drugs 2011, 30(4):1736-1742.
22. García Sar D., Aguado L., Montes Bayón M., Comendador M.A., Blanco González E., Sanz-Medel A., Sierra L.M. Relationships between cisplatin-induced adducts and DNA strand-breaks, mutation and recombination in vivo in somatic cells of Drosophila melanogaster, under different conditions of nucleotide excision repair. Mutat. Res. 2012, 741(1-2):81-88.
23. Matuo R., Sousa F.G., Escargueil A.E., Grivicich I., Garcia-Santos D., Bogo Chies J., Larsenb A.K., Pêgas Henriquesa J.A. 5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line. J. Appl. Toxicol. 2009, 29:308-316.
24. Smart D.J., Halicka H.D., Schmuck G., Traganos F., Darzynkiewicz Z., Williams G.M. Assessment of DNA double-strand breaks and (H2AX induced by the topoisomerase II poisons etoposide and mitoxantrone. Mutat. Res. 2008, 641(1-2):43-47.
25. Fabarius A., Giehl M., Frank O., Spiess B., Zheng C., Muller M.C., Weiss C., Duesberg P., Hehlmann R., Hochhaus A., Seifarth W. Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability. Br. J. Haematol. 2007, 138:369-373.
26. Wisniewska-Jarosinska M., Sliwinski T., Kasznicki J., Kaczmarczyk D., Krupa R., Bloch K., Drzewoski J., Chojnacki J., Blasiak J., Morawiec-Sztandera A. Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells. Mol. Biol. Rep. 2011, 38:3679-3688.
27. Lantzsch H., Gebel T. Genotoxicity of selected metal compounds in the SOS chromotest. Mutat. Res. 1997, 389(2-3):191-197.
28. Yasunaga K., Kiyonari A., Nakagawa M., Yoshikawa K. Investigation into the ability of the Salmonella umu test to detect DNA damage using antitumor drugs. Toxicol. In Vitro 2006, 20:712-728.
29. Reifferscheid T., Grummt T. Genotoxicity in German surface waters-results of a collaborative study. Environmental Challenges 2000, 67-79. Springer, Netherlands. S. Belkin (Ed.).
30. Novartis Material Safety Data Sheet-Gleevec™ 100mg 2003, Novartis Pharmaceuticals Corporation.
31. Kostoryz E.L., Yourtee D.M. Oxidative mutagenesis of doxorubicin-Fe(III) complex. Mutat. Res. 2001, 490(2):131-139.
32. Ferk F., Misík M., Grummt T., Majer B., Fuerhacker M., Buchmann C., Vital M., Uhl M., Lenz K., Grillitsch B., Parzefall W., Nersesyan A., Knasmüller S. Genotoxic effects of wastewater from an oncological ward. Mutat. Res. 2009, 672(2):69-75.
33. Nebot N., Crettol S., d'Esposito F., Tattam B., Hibbs D.E., Murray M. Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. Br. J. Pharmacol. 2010, 161(5):1059-1069.
34. Tabata T., Katoh M., Tokudome S., Hosakawa M., Chiba K., Nakajima M., Yokoi T. Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation. Drug Metab. Dispos. 2004, 32(7):762-767.